![]() |
市場調査レポート
商品コード
1737111
従来型創傷ケアの世界市場:製品、用途、エンドユーザー、地域別(2026年~2032年)Traditional Wound Care Market by Product (Gauze, Tape, Bandage, Cotton), Application (Chronic Wounds, Acute Wounds), End-User (Hospitals, Specialty Clinics, Home Healthcare), & Region for 2026-2032 |
||||||
|
従来型創傷ケアの世界市場:製品、用途、エンドユーザー、地域別(2026年~2032年) |
出版日: 2025年05月08日
発行: Verified Market Research
ページ情報: 英文 202 Pages
納期: 2~3営業日
|
高度創傷ケア製品への意識の高まりが、従来型創傷ケア市場の市場規模を押し上げています。Verified Market Researchのアナリストによると、世界の従来型創傷ケアの市場規模は、2024年に評価された約56億4,000万米ドルから拡大し、2032年までに74億5,000万米ドルの評価額に達すると予測されています。
従来型創傷ケア市場の急速な拡大は、主に慢性創傷の有病率の上昇に起因しており、効果的な創傷管理ソリューションに対する需要が高まっています。2026年~2032年のCAGRは3.54%となる見通しです。
従来型創傷ケア市場の定義/概要
従来型創傷ケアとは、創傷の治療と管理に使用される方法と製品を指し、ドレッシング材、包帯、局所軟膏などが含まれます。このアプローチは、軽度の切り傷、擦り傷、手術創によく利用され、保湿や感染に対するバリア形成を通じて必要不可欠な保護を提供し、治癒を促進します。創傷ケアに伴う合併症を予防しながら治癒プロセスを促進するために、湿潤から乾燥までのドレッシング材やガーゼの当て方など、様々なテクニックが用いられています。
慢性創傷の世界的な増加に伴い、効果的な創傷管理の重要性がますます強調されています。従来型創傷ケア市場の成長を支えているのは、人口の高齢化、糖尿病や肥満率の急増、適切な創傷ケアの実践に対する意識の高まりなどの要因です。さらに、製品処方の進歩や革新的技術の統合が市場拡大に大きく貢献すると予想されます。
当社のレポートには、実用的なデータと将来を見据えた分析が含まれており、ピッチの作成、ビジネスプランの作成、プレゼンテーションの構築、提案書の作成に役立ちます。
慢性創傷の有病率の増加は、従来型創傷ケア市場の成長に影響を与える重要な要因として認識されています。糖尿病、血管疾患、高齢化などの要因が、治癒の遅い創傷を引き起こす疾患の発生率を高めています。このような慢性疾患を患う患者の増加に伴い、効果的な創傷管理ソリューションへの需要が高まっています。世界保健機関(WHO)は、糖尿病患者数が2014年の4億2,200万人から2045年には6億2,900万人に増加すると予測しており、従来型創傷ケア製品に対する需要は急増すると予想されています。
その結果、こうしたニーズに対応するために従来型創傷ケア製品がより頻繁に利用されるようになり、市場規模の拡大につながっています。適切な創傷ケアによって患者の予後を改善するという継続的な焦点も市場力学に反映されており、新しい技術とともに伝統的な方法の採用が強化されています。
高度創傷ケア技術の利用可能性の高まりにより、従来型創傷ケア市場は様々な抑制要因に直面しています。生物活性ドレッシング材や陰圧創傷ケアなど、より高度で専門的な製品へのシフトは、従来型創傷ケア方法に対する潜在的な課題として認識されています。
ヘルスケア提供者がこうした革新的なソリューションを採用するようになるにつれ、従来のアプローチは影を潜め、市場の成長を制限する可能性があります。さらに、ヘルスケア施設における予算の制約から、より効果的と思われがちな先進的な創傷ケア製品が好まれるようになっています。その結果、従来型の創傷ケア製品は、技術の進歩がますます優位に立つ競合情勢の中で、市場シェアの維持に苦戦を強いられる可能性があります。
Increasing awareness of advanced wound care products is driving the market size of the traditional wound care market. According to the analyst from Verified Market Research, the Traditional Wound Care Market is estimated to reach a valuation of USD 7.45 Billion By 2032 over the forecast subjugating around USD 5.64 Billion valued in 2024.
The rapid expansion of the traditional wound care market is primarily driven by the rising prevalence of chronic wounds, which is increasing the demand for effective wound management solutions. It enables the market to grow at a CAGR of 3.54% from 2026 to 2032.
Traditional Wound Care Market: Definition/ Overview
Traditional wound care refers to the methods and products used to treat and manage wounds, which include dressings, bandages, and topical ointments. This approach is often utilized for minor cuts, abrasions, and surgical wounds, providing essential protection and promoting healing through moisture retention and barrier formation against infections. Various techniques, such as wet-to-dry dressings and gauze applications, are employed to facilitate the healing process while preventing complications associated with wound care.
Increasing emphasis is placed on the importance of effective wound management as the global incidence of chronic wounds rises. The growth of the traditional wound care market is supported by factors such as an aging population, a surge in diabetes and obesity rates, and a growing awareness of proper wound care practices. Furthermore, advancements in product formulations and the integration of innovative technologies are expected to contribute significantly to market expansion.
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
The increasing prevalence of chronic wounds is being recognized as a significant driver affecting the growth of the traditional wound care market. Factors such as diabetes, vascular diseases, and an aging population are contributing to a higher incidence of conditions that result in slow-healing wounds. As the number of individuals suffering from these chronic conditions rises, the demand for effective wound management solutions is being escalated. With the World Health Organization projecting the number of people with diabetes to rise from 422 million in 2014 to 629 million by 2045, the demand for traditional wound care products is expected to surge.
Consequently, traditional wound care products are being utilized more frequently to address these needs, thus leading to an expansion in market size. The ongoing focus on improving patient outcomes through proper wound care is also being reflected in the market dynamics, enhancing the adoption of traditional methods alongside newer technologies.
Various restraints are being faced by the traditional wound care market due to the rising availability of advanced wound care technologies. The shift toward more sophisticated and specialized products, such as bioactive dressings and negative pressure wound therapy, is being observed as a potential challenge for traditional wound care methods.
As healthcare providers increasingly adopt these innovative solutions, traditional approaches are being overshadowed, which may limit market growth. Additionally, budget constraints in healthcare facilities are leading to a preference for advanced wound care products, which are often perceived as more effective. As a result, traditional wound care products may struggle to maintain their market share in a competitive landscape increasingly dominated by technological advancements.
According to VMR analyst, the dominating product segment within the traditional wound care market is gauze, which is widely utilized due to its versatility and effectiveness in wound management. Gauze products are preferred for their ability to absorb exudate while allowing airflow to the wound, which is essential for the healing process.
Various types of gauze, including sterile and non-sterile options, are being offered to cater to diverse clinical needs. The widespread availability and cost-effectiveness of gauze are also contributing to its popularity among healthcare providers. As a result, gauze is being recognized as a staple in both hospital and home healthcare settings, further solidifying its position as the leading product in the market.
Why Chronic Wounds is Experiencing Rapid Growth in the Traditional Wound Care Market?
According to VMR analyst, the chronic wounds segment is experiencing rapid growth in the traditional wound care market, which are increasingly being recognized for their complex management requirements. Conditions such as diabetes and venous ulcers are leading to a rise in chronic wounds, necessitating effective treatment solutions.
As the prevalence of these conditions increases, the demand for products specifically designed for chronic wound care is being amplified. Innovative treatment options and enhanced education regarding chronic wound management are also contributing to this growth. Consequently, healthcare providers are focusing on developing tailored care strategies, ensuring that the chronic wound application sub-segment remains at the forefront of market expansion.
According to VMR analyst, various factors are contributing to North America's dominance in the traditional wound care market, with a robust healthcare infrastructure being a significant element. High healthcare expenditure in the region is facilitating access to advanced medical technologies and wound care products.
Additionally, the increasing prevalence of chronic wounds, driven by an aging population and rising rates of diabetes, is being observed in North America, creating a strong demand for effective wound management solutions. According to the U.S. Census Bureau, by 2032, all baby boomers will be older than 65, expanding the size of the older population so that 1 in every 5 residents will be of retirement age. The number of Americans ages 65 and older is projected to nearly double from 52 million in 2018 to 95 million by 2060.
Comprehensive reimbursement policies are also being implemented, ensuring that wound care products are widely accessible to patients. Consequently, these factors are being recognized as crucial drivers of market growth, solidifying North America's position as a leader in the traditional wound care market.
According to VMR analyst, the Asia Pacific region is experiencing rapid growth in the traditional wound care market due to several key factors, including a rising population and increasing awareness of healthcare standards. Economic development in countries such as China and India are leading to improvements in healthcare access and infrastructure, which are fostering greater adoption of wound care products.
Additionally, the growing prevalence of lifestyle-related chronic diseases is resulting in a higher incidence of wounds requiring management. According to the IDF Diabetes Atlas, the number of adults with diabetes in the Western Pacific region was approximately 162.6 million in 2019 and is projected to rise to 260 million by 2045, representing a significant increase of about 27%.
Government initiatives aimed at enhancing healthcare services are also being implemented, thereby supporting market growth. As a result, the Asia Pacific region is being positioned as a rapidly expanding market within the traditional wound care sector, with significant potential for future developments.
The Traditional Wound Care Market's competitive landscape is characterized by a varied range of companies, including technology developers, plant operators, and service providers, all striving for market share in an increasingly dynamic and growing industry.
Some of the prominent players operating in the traditional wound care market include:
Braun Melsungen AG
Coloplast A/S
Convatec Group plc
Dermarite Industries LLC.
Deroyal Industries, Inc.
Hollister Incorporated
Integra Lifesciences Holdings Corporation
Johnson & Johnson Private Limited
Medtronic plc.
Molnlycke Health Care Ab
Paul Hartmann AG
Smith & Nephew plc.
In April 2024, M Health Care's innovative 3M(TM) Veraflo(TM) Therapy, with both 3M(TM) Veraflo(TM) Cleanse Choice Complete(TM) Dressing and 3M(TM) V.A.C. Veraflo Cleanse Choice(TM) Dressing, received the first-ever Food and Drug Administration (FDA) clearance for hydromechanical removal of infectious materials, non-viable tissue, and wound debris. This reduces the number of surgical debridements required while promoting granulation tissue formation and creating an environment that promotes wound healing.